echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > New optogenetic tools make it possible to treat multiple diseases with one beam of light

    New optogenetic tools make it possible to treat multiple diseases with one beam of light

    • Last Update: 2021-10-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    A new study published online on the 4th in the British journal "Nature Biotechnology" shows that new optogenetic tools developed by Chinese researchers are making it possible for a beam of light to be used to treat tumors, metabolic diseases and many other diseases.

    .
     
    After the advent of optogenetics more than ten years ago, the field of neuroscience has begun to use this treatment method
    .
    In recent years, researchers have built a series of optogenetic tools through the mining and design of light-sensitive proteins and applied them to the treatment of tumors and metabolic diseases , which is of great significance in the fields of precise and controllable gene therapy and cell therapy.
    , But there are still many problems that need to be overcome to truly realize the use of a beam of light to cure diseases
    .
     
    In the latest research, researchers from the School of Life Sciences, East China Normal University, Shanghai Key Laboratory of Regulatory Biology, and East China Normal University Medical Synthetic Biology Research Center took 5 years to develop a new type of optogenetics with small modules and high sensitivity.
    Learning tool-REDMAP system
    .
     
    Studies have shown that the REDMAP system has good spectral specificity and a high degree of reversibility
    .
    The system also has ultra-high sensitivity.
    It only needs to irradiate red light for 1 second to achieve a gene expression effect of more than 150 times
    .
     
    According to reports, an ideal optogenetic tool that can be used in clinics needs to meet several characteristics: First, it responds to red light or far-red light, which has good tissue penetration and almost no phototoxicity, and has relatively high Good in vivo application potential; second, the system components are small, can be packaged by adeno-associated viruses with better safety, and can be widely used in gene therapy and basic medical research; third, the sensitivity is high, the light response speed is fast and can be turned off at any time, It has good reversibility and can be flexibly adjusted according to actual needs and application scenarios
    .
    However, none of the previous optogenetic tools can meet the above conditions at the same time
    .
     
    The head of the research team, Ye Haifeng, told Xinhua News Agency reporters on the 4th: “The latest research result is an optogenetic tool that fully meets the above requirements.
    Cell gene expression can also be used in many fields such as the control of cell signaling pathways, gene editing, and the treatment of diabetes
    .
    "
    A new study published online on the 4th in the British journal "Nature Biotechnology" shows that new optogenetic tools developed by Chinese researchers are making it possible for a beam of light to be used to treat tumors, metabolic diseases and many other diseases.

    .
     
    After the advent of optogenetics more than ten years ago, the field of neuroscience has begun to use this treatment method
    .
    In recent years, researchers have built a series of optogenetic tools through the mining and design of light-sensitive proteins and applied them to the treatment of tumors and metabolic diseases , which is of great significance in the fields of precise and controllable gene therapy and cell therapy.
    , But there are still many problems that need to be overcome to truly realize the use of a beam of light to cure diseases
    .
     
      In the latest research, researchers from the School of Life Sciences, East China Normal University, Shanghai Key Laboratory of Regulatory Biology, and East China Normal University Medical Synthetic Biology Research Center took 5 years to develop a new type of optogenetics with small modules and high sensitivity.
    Learning tool-REDMAP system
    .
     
      Studies have shown that the REDMAP system has good spectral specificity and a high degree of reversibility
    .
    The system also has ultra-high sensitivity.
    It only needs to irradiate red light for 1 second to achieve a gene expression effect of more than 150 times
    .
     
      According to reports, an ideal optogenetic tool that can be used in clinics needs to meet several characteristics: First, it responds to red light or far-red light, which has good tissue penetration and almost no phototoxicity, and has relatively high Good in vivo application potential; second, the system components are small, can be packaged by adeno-associated viruses with better safety, and can be widely used in gene therapy and basic medical research; third, the sensitivity is high, the light response speed is fast and can be turned off at any time, It has good reversibility and can be flexibly adjusted according to actual needs and application scenarios
    .
    However, none of the previous optogenetic tools can meet the above conditions at the same time
    .
     
      The head of the research team, Ye Haifeng, told Xinhua News Agency reporters on the 4th: “The latest research result is an optogenetic tool that fully meets the above requirements.
    Cell gene expression can also be used in many fields such as the control of cell signaling pathways, gene editing, and the treatment of diabetes
    .
    "
      A new study published online on the 4th in the British journal "Nature Biotechnology" shows that new optogenetic tools developed by Chinese researchers are making it possible for a beam of light to be used to treat tumors, metabolic diseases and many other diseases.

    .
     
      After the advent of optogenetics more than ten years ago, the field of neuroscience has begun to use this treatment method
    .
    In recent years, researchers have built a series of optogenetic tools through the mining and design of light-sensitive proteins and applied them to the treatment of tumors and metabolic diseases , which is of great significance in the fields of precise and controllable gene therapy and cell therapy.
    , But there are still many problems that need to be overcome to truly realize the use of a beam of light to cure diseases
    .
    Tumor tumor tumor disease disease disease
     
      In the latest research, researchers from the School of Life Sciences, East China Normal University, Shanghai Key Laboratory of Regulatory Biology, and East China Normal University Medical Synthetic Biology Research Center took 5 years to develop a new type of optogenetics with small modules and high sensitivity.
    Learning tool-REDMAP system
    .
     
      Studies have shown that the REDMAP system has good spectral specificity and a high degree of reversibility
    .
    The system also has ultra-high sensitivity.
    It only needs to irradiate red light for 1 second to achieve a gene expression effect of more than 150 times
    .
     
      According to reports, an ideal optogenetic tool that can be used in clinics needs to meet several characteristics: First, it responds to red light or far-red light, which has good tissue penetration and almost no phototoxicity, and has relatively high Good in vivo application potential; second, the system components are small, can be packaged by adeno-associated viruses with better safety, and can be widely used in gene therapy and basic medical research; third, the sensitivity is high, the light response speed is fast and can be turned off at any time, It has good reversibility and can be flexibly adjusted according to actual needs and application scenarios
    .
    However, none of the previous optogenetic tools can meet the above conditions at the same time
    .
     
      The head of the research team, Ye Haifeng, told Xinhua News Agency reporters on the 4th: “The latest research result is an optogenetic tool that fully meets the above requirements.
    Cell gene expression can also be used in many fields such as the control of cell signaling pathways, gene editing, and the treatment of diabetes
    .
    "
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.